Literature DB >> 21229605

RMI1 attenuates tumor development and is essential for early embryonic survival.

H Chen1, M J You, Y Jiang, W Wang, L Li.   

Abstract

RMI1/BLAP75 (RecQ-mediated genome instability 1/Bloom-associated protein 75) is an OB-fold protein highly conserved from yeast to human. Previous studies showed that RMI1 is required for the stability of the BLM/RMI1/Top3α complex and for the suppression of elevated sister chromatids exchange (SCE). The presence of RMI1 strongly stimulates Holliday dissolution activity of the Bloom helicase in vitro. The in vivo function of RMI1, however, remains largely undefined. To address this question, we generated RMI1 knockout mice through homologous replacement targeting. We found that, while RMI1 +/⁻ mice showed no obvious developmental phenotype, deletion of both mRMI1 alleles resulted in early embryonic lethality before implantation. To determine whether RMI1 plays a role in tumorigenesis, we generated RMI1/p53 double heterozygous mice and analyzed their onset of ionizing radiation-induced tumor development. RMI1 +/⁻/p53 +/⁻ mice succumbed to tumor with a higher frequency and exhibited a substantially shortened survival when compared to the wild type, RMI1 +/⁻ and p53 +/⁻ cohorts. These results demonstrated a dual-role of RMI1 in embryonic development and tumor suppression.
Copyright © 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21229605      PMCID: PMC3079784          DOI: 10.1002/mc.20694

Source DB:  PubMed          Journal:  Mol Carcinog        ISSN: 0899-1987            Impact factor:   4.784


  37 in total

1.  ATR and ATM-dependent movement of BLM helicase during replication stress ensures optimal ATM activation and 53BP1 focus formation.

Authors:  Albert R Davalos; Patrick Kaminker; Rhonda K Hansen; Judith Campisi
Journal:  Cell Cycle       Date:  2004-12-04       Impact factor: 4.534

2.  Requirement for p53 and p21 to sustain G2 arrest after DNA damage.

Authors:  F Bunz; A Dutriaux; C Lengauer; T Waldman; S Zhou; J P Brown; J M Sedivy; K W Kinzler; B Vogelstein
Journal:  Science       Date:  1998-11-20       Impact factor: 47.728

3.  The HRDC domain of BLM is required for the dissolution of double Holliday junctions.

Authors:  Leonard Wu; Kok Lung Chan; Christine Ralf; Douglas A Bernstein; Patrick L Garcia; Vilhelm A Bohr; Alessandro Vindigni; Pavel Janscak; James L Keck; Ian D Hickson
Journal:  EMBO J       Date:  2005-06-30       Impact factor: 11.598

4.  BLAP75, an essential component of Bloom's syndrome protein complexes that maintain genome integrity.

Authors:  Jinhu Yin; Alexandra Sobeck; Chang Xu; Amom Ruhikanta Meetei; Maureen Hoatlin; Lei Li; Weidong Wang
Journal:  EMBO J       Date:  2005-03-17       Impact factor: 11.598

5.  RMI1/NCE4, a suppressor of genome instability, encodes a member of the RecQ helicase/Topo III complex.

Authors:  Michael Chang; Mohammed Bellaoui; Chaoying Zhang; Ridhdhi Desai; Pavel Morozov; Lissette Delgado-Cruzata; Rodney Rothstein; Greg A Freyer; Charles Boone; Grant W Brown
Journal:  EMBO J       Date:  2005-05-12       Impact factor: 11.598

6.  Mammalian DNA topoisomerase IIIalpha is essential in early embryogenesis.

Authors:  W Li; J C Wang
Journal:  Proc Natl Acad Sci U S A       Date:  1998-02-03       Impact factor: 11.205

7.  Yeast Rmi1/Nce4 controls genome stability as a subunit of the Sgs1-Top3 complex.

Authors:  Janet R Mullen; Ferez S Nallaseth; Yan Q Lan; Christopher E Slagle; Steven J Brill
Journal:  Mol Cell Biol       Date:  2005-06       Impact factor: 4.272

8.  Stage-specific apoptosis, developmental delay, and embryonic lethality in mice homozygous for a targeted disruption in the murine Bloom's syndrome gene.

Authors:  N Chester; F Kuo; C Kozak; C D O'Hara; P Leder
Journal:  Genes Dev       Date:  1998-11-01       Impact factor: 11.361

9.  Functional analysis of Gscl in the pathogenesis of the DiGeorge and velocardiofacial syndromes.

Authors:  M Wakamiya; E A Lindsay; J A Rivera-Pérez; A Baldini; R R Behringer
Journal:  Hum Mol Genet       Date:  1998-11       Impact factor: 6.150

10.  Atm heterozygous deficiency enhances development of mammary carcinomas in p53 heterozygous knockout mice.

Authors:  Seiichi Umesako; Kae Fujisawa; Sayoko Iiga; Nobuko Mori; Masahiro Takahashi; Doo-Pyo Hong; Chang-Woo Song; Satomi Haga; Syunsuke Imai; Otsura Niwa; Masaaki Okumoto
Journal:  Breast Cancer Res       Date:  2004-12-10       Impact factor: 6.466

View more
  6 in total

Review 1.  The dissolution of double Holliday junctions.

Authors:  Anna H Bizard; Ian D Hickson
Journal:  Cold Spring Harb Perspect Biol       Date:  2014-07-01       Impact factor: 10.005

2.  Genome instability and embryonic developmental defects in RMI1 deficient mice.

Authors:  Michel F Guiraldelli; Craig Eyster; Roberto J Pezza
Journal:  DNA Repair (Amst)       Date:  2013-07-27

3.  Hsa_circ_0091581 promotes glioma progression by regulating RMI1 via sponging miR-1243-5p.

Authors:  Jin Qian; Yingna Xu; Xing Xu; Zhenyu Tao; Yang Luo; Yichang Xu; Yong Zhang; Chunfa Qian
Journal:  J Cancer       Date:  2021-04-02       Impact factor: 4.207

4.  Structural Motifs Critical for In Vivo Function and Stability of the RecQ-Mediated Genome Instability Protein Rmi1.

Authors:  Jessica A Kennedy; Salahuddin Syed; Kristina H Schmidt
Journal:  PLoS One       Date:  2015-12-30       Impact factor: 3.240

5.  The Bloom syndrome complex senses RPA-coated single-stranded DNA to restart stalled replication forks.

Authors:  Ann-Marie K Shorrocks; Samuel E Jones; Kaima Tsukada; Carl A Morrow; Zoulikha Belblidia; Johanna Shen; Iolanda Vendrell; Roman Fischer; Benedikt M Kessler; Andrew N Blackford
Journal:  Nat Commun       Date:  2021-01-26       Impact factor: 14.919

6.  Improved Genome Editing through Inhibition of FANCM and Members of the BTR Dissolvase Complex.

Authors:  Gustavo de Alencastro; Francesco Puzzo; Mara Pavel-Dinu; Feijie Zhang; Sirika Pillay; Karim Majzoub; Matthew Tiffany; Hagoon Jang; Adam Sheikali; M Kyle Cromer; Ruhikanta Meetei; Jan E Carette; Matthew H Porteus; Katja Pekrun; Mark A Kay
Journal:  Mol Ther       Date:  2020-10-22       Impact factor: 11.454

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.